Hamlin DK - Search Results

1

Targeted Radiation Delivery before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-term Survivors.

Orozco JJ, Vo PT, Gooley TA, Haaf RL, Lundberg SJ, Hamlin DK, Wilbur DS, Matesan MC, Fisher DR, Gopal AK, Green DJ, Pagel JM, Sandmaier BM. Orozco JJ, et al. Among authors: hamlin dk. Clin Cancer Res. 2024 Jan 17;30(2):274-282. doi: 10.1158/1078-0432.CCR-23-1200. Clin Cancer Res. 2024. PMID: 37939122 Clinical Trial.

2

[²¹¹At]astatine-based anti-CD22 radioimmunotherapy for B-cell malignancies.

Laszlo GS, Sandmaier BM, Kehret AR, Orozco JJ, Hamlin DK, Dexter SL, Lim SYT, Cole FM, Huo J, Wilbur DS, Walter RB. Laszlo GS, et al. Among authors: hamlin dk. Leuk Lymphoma. 2023 Jul-Aug;64(7):1335-1339. doi: 10.1080/10428194.2023.2210710. Epub 2023 May 11. Leuk Lymphoma. 2023. PMID: 37170642 No abstract available.

3

Glypican-3 targeted positron emission tomography detects sub-centimeter tumors in a xenograft model of hepatocellular carcinoma.

Labadie KP, Lehnert AL, Kenoyer AL, Hamlin DK, Ludwig AD, Utria AF, Daniel SK, Mihailovic TN, Prossnitz A, Orozco JJ, Li Y, Wilbur DS, Miyaoka RS, Park JO. Labadie KP, et al. Among authors: hamlin dk. EJNMMI Res. 2023 Apr 27;13(1):35. doi: 10.1186/s13550-023-00980-9. EJNMMI Res. 2023. PMID: 37103671 Free PMC article.

4

Small-scale (sub-organ and cellular level) alpha-particle dosimetry methods using an iQID digital autoradiography imaging system.

Peter R, Sandmaier BM, Dion MP, Frost SHL, Santos EB, Kenoyer A, Hamlin DK, Wilbur DS, Stewart RD, Fisher DR, Vetter K, Seo Y, Miller BW. Peter R, et al. Among authors: hamlin dk. Sci Rep. 2022 Oct 26;12(1):17934. doi: 10.1038/s41598-022-22664-5. Sci Rep. 2022. PMID: 36289434 Free PMC article.

5

Oxidation of p-[¹²⁵I]Iodobenzoic Acid and p-[²¹¹At]Astatobenzoic Acid Derivatives and Evaluation In Vivo.

Li Y, Chyan MK, Hamlin DK, Nguyen H, Corey E, Wilbur DS. Li Y, et al. Among authors: hamlin dk. Int J Mol Sci. 2022 Sep 13;23(18):10655. doi: 10.3390/ijms231810655. Int J Mol Sci. 2022. PMID: 36142567 Free PMC article.

6

Development of [²¹¹At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies.

Laszlo GS, Orozco JJ, Kehret AR, Lunn MC, Huo J, Hamlin DK, Scott Wilbur D, Dexter SL, Comstock ML, O'Steen S, Sandmaier BM, Green DJ, Walter RB. Laszlo GS, et al. Among authors: hamlin dk. Leukemia. 2022 Jun;36(6):1485-1491. doi: 10.1038/s41375-022-01580-7. Epub 2022 Apr 26. Leukemia. 2022. PMID: 35474099 Free PMC article.

7

Glypican-3-Targeted ²²⁷Th α-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma.

Labadie KP, Hamlin DK, Kenoyer A, Daniel SK, Utria AF, Ludwig AD, Kenerson HL, Li L, Sham JG, Chen DL, Orozco JJ, Yeung RS, Orvig C, Li Y, Wilbur DS, Park JO. Labadie KP, et al. Among authors: hamlin dk. J Nucl Med. 2022 Jul;63(7):1033-1038. doi: 10.2967/jnumed.121.262562. Epub 2021 Nov 12. J Nucl Med. 2022. PMID: 34772791 Free PMC article.

8

Addition of Astatine-211-Labeled Anti-CD45 Antibody to TBI as Conditioning for DLA-Identical Marrow Transplantation: A Novel Strategy to Overcome Graft Rejection in a Canine Presensitization Model: "Radioimmunotherapy to Overcome Transfusion-Induced Sensitization".

Nakaya A, Qiu H, Santos EB, Hamlin DK, Wilbur DS, Storb R, Sandmaier BM. Nakaya A, et al. Among authors: hamlin dk. Transplant Cell Ther. 2021 Jun;27(6):476.e1-476.e7. doi: 10.1016/j.jtct.2021.02.018. Epub 2021 Feb 25. Transplant Cell Ther. 2021. PMID: 33775618 Free PMC article.

9

Glypican-3 targeted delivery of ⁸⁹Zr and ⁹⁰Y as a theranostic radionuclide platform for hepatocellular carcinoma.

Labadie KP, Ludwig AD, Lehnert AL, Hamlin DK, Kenoyer AL, Sullivan KM, Daniel SK, Mihailovic TN, Sham JG, Orozco JJ, Yeung RS, Chen DL, Wilbur DS, Miyaoka RS, Park JO. Labadie KP, et al. Among authors: hamlin dk. Sci Rep. 2021 Feb 12;11(1):3731. doi: 10.1038/s41598-021-82172-w. Sci Rep. 2021. PMID: 33580090 Free PMC article.

10

Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and ⁹⁰Y-DOTA.

Orozco JJ, Kenoyer AL, Lin Y, O'Steen S, Guel R, Nartea ME, Hernandez AH, Hylarides MD, Fisher DR, Balkin ER, Hamlin DK, Wilbur DS, Orcutt KD, Wittrup KD, Green DJ, Gopal AK, Till BG, Sandmaier B, Press OW, Pagel JM. Orozco JJ, et al. Among authors: hamlin dk. Mol Cancer Ther. 2020 Dec;19(12):2575-2584. doi: 10.1158/1535-7163.MCT-20-0306. Epub 2020 Oct 20. Mol Cancer Ther. 2020. PMID: 33082277 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page